Katze M G, Wambach M, Wong M L, Garfinkel M, Meurs E, Chong K, Williams B R, Hovanessian A G, Barber G N
Department of Microbiology, School of Medicine, University of Washington, Seattle 98195.
Mol Cell Biol. 1991 Nov;11(11):5497-505. doi: 10.1128/mcb.11.11.5497-5505.1991.
Eukaryotic viruses have devised numerous strategies to downregulate activity of the interferon-induced, double-stranded (dsRNA)-activated protein kinase (referred to as p68 on the basis of its Mr of 68,000 in human cells). Viruses must exert this control to avoid extensive phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eIF-2) by p68 and the resultant negative effects on protein synthesis initiation. To begin to define the molecular mechanisms underlying this regulation, we optimized expression of p68 in an in vitro transcription-translation system utilizing the full-length cDNA clone. The in vitro-expressed kinase was autophosphorylated in response to dsRNAs and heparin in a manner similar to that for the native p68 provided that the kinase inhibitor, 2-aminopurine, was present during the in vitro translation reaction. Further, the activated kinase efficiently phosphorylated its natural substrate, the alpha subunit of eIF-2. Binding experiments revealed that the expressed kinase complexed with the dsRNA activator, reovirus dsRNA, as well as the adenovirus-encoded inhibitor, VAI RNA. Interestingly, both the reovirus RNAs and VAI RNA also complexed with protein kinase molecules that lacked the carboxyl terminus and all catalytic domains. Deletion analysis confirmed that the p68 amino terminus contained critical determinants for reovirus dsRNA and VAI RNA binding. Further, reovirus dsRNA efficiently bound to, but failed to activate, p68 kinase molecules containing a single amino acid substitution in the invariant lysine 295 present in catalytic domain II. Taken together, these data demonstrate that this expression system permits a detailed mutagenic analysis of the regions of p68 required for interaction with virus-encoded activators and repressors.
真核病毒已经设计出多种策略来下调干扰素诱导的双链(dsRNA)激活蛋白激酶(基于其在人细胞中的分子量68,000,称为p68)的活性。病毒必须施加这种控制,以避免p68对真核起始因子2(eIF-2)的α亚基进行广泛磷酸化以及对蛋白质合成起始产生的负面影响。为了开始确定这种调节的分子机制,我们利用全长cDNA克隆在体外转录-翻译系统中优化了p68的表达。只要在体外翻译反应中存在激酶抑制剂2-氨基嘌呤,体外表达的激酶就会以与天然p68类似的方式响应dsRNA和肝素而发生自磷酸化。此外,活化的激酶有效地磷酸化其天然底物eIF-2的α亚基。结合实验表明,表达的激酶与dsRNA激活剂呼肠孤病毒dsRNA以及腺病毒编码的抑制剂VAI RNA复合。有趣的是,呼肠孤病毒RNA和VAI RNA也与缺乏羧基末端和所有催化结构域的蛋白激酶分子复合。缺失分析证实,p68氨基末端包含与呼肠孤病毒dsRNA和VAI RNA结合的关键决定因素。此外,呼肠孤病毒dsRNA有效地结合但未能激活在催化结构域II中存在的不变赖氨酸295中含有单个氨基酸取代的p68激酶分子。总之,这些数据表明该表达系统允许对p68与病毒编码的激活剂和抑制剂相互作用所需区域进行详细的诱变分析。